The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
Open accessAbstract
BACKGROUND AND OBJECTIVES: Hemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. Most childhood cases are caused by Shiga toxin-producing bacteria. The other form, atypical HUS (aHUS), accounts for 10% of cases and has a poor prognosis. Genetic complement abnormalities have been found in aHUS. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: We screened 273 consecutive patients with aHUS for complement abnormalities and studied their role in predicting clinical phenotype and response to treatment. We compared mutation frequencies and localization and clinical outcome in familial (82) and sporadic (191) cases. RESULTS: In >70% of sporadic and familial cases, gene mutations, disease-associated factor H (CFH) polymorphisms, or anti-CFH autoantibodies were found. Either mutations or CFH polymorphisms were also found in the majority of patients with secondary aHUS, suggesting a genetic predisposition. Familial cases showed a higher prevalence of mutations in SCR20 of CFH and more severe disease than sporadic cases. Patients with CFH or THBD (thrombomodulin) mutations had the earliest onset and highest mortality. Membrane-cofactor protein (MCP) mutations were associated with the best prognosis. Plasma therapy induced remission in 55 to 80% of episodes in patients with CFH, C3, or THBD mutations or autoantibodies, whereas patients with CFI (factor I) mutations were poor responders. aHUS recurred frequently after kidney transplantation except for patients with MCP mutations. CONCLUSIONS: Results underline the need of genetic screening for all susceptibility factors as part of clinical management of aHUS and for identification of patients who could safely benefit from kidney transplant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
Self-citationCaprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Self-citationThrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810739 · Cited by 554
Self-citationAnti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura
Ruggenenti, P., Noris, M., & Remuzzi, G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060003831.x · Cited by 489
Self-citationMutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A., & Goodship, T. H. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010103 · Cited by 475
Self-citationde Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
Frémeaux-Bacchi, V., Miller, E. C., Liszewski, M. K., Strain, L., Blouin, J., Brown, A. L., Moghal, N., Kaplan, B. S., Weiss, R. A., Lhotta, K., et al. (2008) · Blood · doi:10.1182/blood-2008-01-133702 · Cited by 372
Self-citationMoore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P. N., Herbert, A. P., Schmidt, C. Q., Staniforth, S. J., Holmes, L. V., Ward, R., et al. (2010) · Blood · doi:10.1182/blood-2009-05-221549 · Cited by 357
Self-citationFactor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
Józsi, M., Licht, C., Strobel, S., Zipfel, S. L. H., Richter, H., Heinen, S., Zipfel, P. F., & Skerka, C. (2008) · Blood · doi:10.1182/blood-2007-09-109876 · Cited by 354
Self-citationGuideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
The European Paediatric Study Group for HUS, Ariceta, G., Besbas, N., Johnson, S., Karpman, D., Landau, D., Licht, C., Loirat, C., Pecoraro, C., Taylor, C. M., et al. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-0964-1 · Cited by 352
Eculizumab for Atypical Hemolytic–Uremic Syndrome
Nürnberger, J., Philipp, T., Witzke, O., Saez, A. O., Vester, U., Baba, H. A., Kribben, A., Zimmerhackl, L. B., Janecke, A. R., Nagel, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0808527 · Cited by 346
Caprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg363 · Cited by 306
Self-citationBesbas, N., Karpman, D., Landau, D., Loirat, C., Proesmans, W., Remuzzi, G., Rizzoni, G., Taylor, C. M., Van de Kar, N., & Zimmerhackl, L. B. (2006) · Kidney International · doi:10.1038/sj.ki.5001581 · Cited by 277
Self-citationEculizumab for Congenital Atypical Hemolytic–Uremic Syndrome
Gruppo, R. A., & Rother, R. P. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0809959 · Cited by 275
Abarrategui-Garrido, C., Martínez-Barricarte, R., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2009) · Blood · doi:10.1182/blood-2009-05-223834 · Cited by 206
Complement and the atypical hemolytic uremic syndrome in children
Loirat, C., Noris, M., & Frémeaux‐Bacchi, V. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0872-4 · Cited by 206
Self-citationComplement Mutation-Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation
Le Quintrec, M., Lionet, A., Kamar, N., Karras, A., Barbier, S., Buchler, M., Fakhouri, F., Provost, F., Fridman, W. H., Thervet, E., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02297.x · Cited by 203
Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
Venables, J. P., Strain, L., Routledge, D., Bourn, D., Powell, H. M., Warwicker, P., Diaz-Torres, M. L., Sampson, A., Mead, P., Webb, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030431 · Cited by 195
Self-citationBienaime, F., Dragon-Durey, M.-A., Regnier, C. H., Nilsson, S. C., Kwan, W. H., Blouin, J., Jablonski, M., Renault, N., Rameix-Welti, M.-A., Loirat, C., et al. (2010) · Kidney International · doi:10.1038/ki.2009.472 · Cited by 192
The complement system in the pathophysiology of pregnancy
Girardi, G., Bulla, R., Salmon, J. E., & Tedesco, F. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.06.017 · Cited by 186
Liver-Kidney Transplantation to Cure Atypical Hemolytic Uremic Syndrome
Saland, J. M., Ruggenenti, P., & Remuzzi, G. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080906 · Cited by 165
Self-citationRoumenina, L. T., Jablonski, M., Hue, C., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197640 · Cited by 157
Dragon‐Durey, M., Blanc, C., Marliot, F., Loirat, C., Blouin, J., Sautès‐Fridman, C., Fridman, W. H., & Frémeaux‐Bacchi, V. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.064766 · Cited by 156
Combined kidney and liver transplantation for familial haemolytic uraemic syndrome
Remuzzi, G., Ruggenenti, P., Codazzi, D., Noris, M., Caprioli, J., Locatelli, G., & Gridelli, B. G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08560-4 · Cited by 148
Self-citationComplement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome
Mache, C. J., Acham‐Roschitz, B., Frémeaux‐Bacchi, V., Kirschfink, M., Zipfel, P. F., Rödl, S., Vester, U., & Ring, E. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01090209 · Cited by 148
Self-citationSoluble Thrombomodulin Protects Ischemic Kidneys
Sharfuddin, A., Sandoval, R. M., Berg, D. T., McDougal, G., Campos, S. B., Phillips, C. L., Jones, B. E., Gupta, A., Grinnell, B. W., & Molitoris, B. A. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060593 · Cited by 130
Factor H and Atypical Hemolytic Uremic Syndrome
Józsi, M., Heinen, S., Hartmann, A., Ostrowicz, C. W., Hälbich, S., Richter, H., Kunert, A., Licht, C. P. B., Saunders, R. E., Perkins, S. J., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080868 · Cited by 124
Self-citationHereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis
Frémeaux‐Bacchi, V., & Licht, C. P. B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-09-0575 · Cited by 61
Complement and Renal Transplantation: From Donor to Recipient
Damman, J. J., Schuurs, T. A., Ploeg, R. J., & Seelen, M. A. (2008) · Transplantation · doi:10.1097/tp.0b013e3181683cf5 · Cited by 55
Polyanion-Induced Self-Association of Complement Factor H
Pangburn, M. K., Rawal, N., Cortés, C., Alam, M. N., Ferreira, V. P., & Atkinson, M. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.1061 · Cited by 53
Update on evaluating complement in hemolytic uremic syndrome
Kavanagh, D., & Goodship, T. H. J. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f0872f · Cited by 14
Self-citation
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C., Bingham, C., Cohen, D. J., Delmas, Y., Douglas, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208981 · Cited by 1,586
Self-citationAtypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
Self-citationSyndromes of Thrombotic Microangiopathy
George, J. N., & Nester, C. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312353 · Cited by 1,279
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Metadata
- Authors
- Noris, M., Caprioli, J., Bresin, E., Mossali, C., Pianetti, G., Gamba, S., Daina, E., Fenili, C., Castelletti, F., Sorosina, A., Piras, R., Donadelli, R., Maranta, R., van der Meer, I., Conway, E. M., Zipfel, P. F., Goodship, T. H., & Remuzzi, G.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2010-10
- Volume
- 5
- Issue
- 10
- Pages
- 1844-1859
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2123753762
- Cited by
- 1,042
- References
- 32
- FWCI
- 11.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.